Home › Funds › Catalio Capital Management, LP › DNTH

Catalio Capital Management, LP position in DNTH

DIANTHUS THERAPEUTICS INC COM · Health Care

Catalio Capital Management, LP reported holding 32,941 shares of DNTH (DIANTHUS THERAPEUTICS INC COM) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 0.60% of its reported portfolio and ranking #32 among its reported holdings. Catalio Capital Management, LP has disclosed DNTH holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)32.94K sh
Reported value held$3.21M
Portfolio Weight0.60%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Catalio Capital Management, LP's DNTH position evolved

Catalio Capital Management, LP first disclosed a stake in DNTH in Q4 2024 at 763,471 shares (US$16.6M). The position peaked in Q1 2026 at 560,308 shares, worth US$47.0M. Across 7 filings, Catalio Capital Management, LP increased the stake 0 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 32,941 shares valued at US$3.2M — a reduction of -527,367 shares quarter over quarter.. Notable position changes include a 94% trim in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 763.47K $16.64M New
Q1 2025 763.47K $13.85M Hold
Q2 2025 746.53K $13.91M Reduce
Q3 2025 667.62K $26.27M Reduce
Q4 2025 653.57K $26.93M Reduce
Q1 2026 560.31K $47.02M Reduce
Q2 2026 32.94K $3.21M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC COM) is a Health Care company. 73 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has Catalio Capital Management, LP held DNTH?

Catalio Capital Management, LP has disclosed DNTH holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Catalio Capital Management, LP's current position in DNTH?

As of Q2 2026, Catalio Capital Management, LP holds 32.94K shares of DNTH (DIANTHUS THERAPEUTICS INC COM), valued at $3.21M, representing 0.60% of its reported portfolio and ranking #32.

Has Catalio Capital Management, LP been buying or selling DNTH?

In the latest 13F filing (Q2 2026), Catalio Capital Management, LP reduced its position in DNTH. The position peaked in Q1 2026 at 560.31K shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.